Skip to content

Released Nov 2, 2012, during market hours

10-Q filed Nov 2, 2012, 33 days after period end · 0001193125-12-448885

Q3 2012 · 10-Q
Revenue$105.82M−5.1% vs Q3 2011−5.2% vs Q2 2012
Net Income$3.75M−62.8% vs Q3 2011−57.4% vs Q2 2012
EPS Diluted$0.19−64.8% vs Q3 2011−58.7% vs Q2 2012
Gross Profit$80,931,000−8.4%
Operating Income$16,943,000−19.2%
Operating Cash Flowderived$10,638,000−34.3%
Free Cash Flowderived$5,220,000−49.5%
Margins · derived
Gross margin76.5%−2.8 pt vs Q3 2011
Operating margin16.0%−2.8 pt vs Q3 2011
Net margin3.5%−5.5 pt vs Q3 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2012Q3 2011Q3 2010
Revenue$105.82M$111.51M$138.91M
Net Income$3.75M$10.08M$8.52M
EPS Diluted$0.19$0.54$0.48

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR